[1]
Y. Kim and D. Shin, “CLINICAL RESULTS OF LONG-TERM LOBEGLITAZONE ADD-ON THERAPY IN TYPE 2 DIABETES”, J ASEAN Fed Endocr Soc, vol. 38, no. S3, pp. 71–72, Nov. 2023.